These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36082864)

  • 21. Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research.
    Al-Lawati H; Binkhathlan Z; Lavasanifar A
    Eur J Pharm Biopharm; 2019 Sep; 142():179-194. PubMed ID: 31233861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery and targeting of nanoparticles into hair follicles.
    Fang CL; Aljuffali IA; Li YC; Fang JY
    Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
    Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
    Hock SC; Ying YM; Wah CL
    PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanotechnology for nanomedicine and delivery of drugs.
    Venugopal J; Prabhakaran MP; Low S; Choon AT; Zhang YZ; Deepika G; Ramakrishna S
    Curr Pharm Des; 2008; 14(22):2184-200. PubMed ID: 18781971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points].
    Killestein J; Nelemans SA
    Ned Tijdschr Geneeskd; 1997 Aug; 141(35):1689-93. PubMed ID: 9543785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nano-Scale Gene Delivery Systems: Current Technology, Obstacles, and Future Directions.
    Garcia-Guerra A; Dunwell TL; Trigueros S
    Curr Med Chem; 2018; 25(21):2448-2464. PubMed ID: 29308734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanodrugs used in cancer therapy.
    Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation.
    Nagar N; Naidu G; Mishra A; Poluri KM
    J Pharmacol Exp Ther; 2024 Jan; 388(1):91-109. PubMed ID: 37699711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Nanomedicine: Challenges and Opportunities.
    Deng B; Liu S; Wang Y; Ali B; Kong N; Xie T; Koo S; Ouyang J; Tao W
    Adv Mater; 2024 Feb; 36(6):e2306081. PubMed ID: 37724825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.
    Ali Khan A; Mudassir J; Mohtar N; Darwis Y
    Int J Nanomedicine; 2013; 8():2733-44. PubMed ID: 23926431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
    Iqbal HMN; Rodriguez AMV; Khandia R; Munjal A; Dhama K
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):86-93. PubMed ID: 27978790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-engineered imaging agent using biomimetic approaches.
    Nguyen TDT; Marasini R; Aryal S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1762. PubMed ID: 34698438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of nanotechnology in the prolonged release of drugs by the subcutaneous route.
    Rama B; Ribeiro AJ
    Expert Opin Drug Deliv; 2023 May; 20(5):559-577. PubMed ID: 37305971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoids and atherosclerosis.
    Fisar Z
    Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.